The hypothalamic mechanisms of the hypophysiotropic action of ghrelin

Neuroendocrinology

Volumn 76, Issue 5, 2002, Pages 316-324

  Wren, Alison M ^a   Small, Caroline J ^a   Fribbens, Charlotte V ^a   Neary, Nicola M ^a   Ward, Helen L ^a   Seal, Leighton J ^a   Ghatei, Mohammad A ^a   Bloom, Stephen Robert ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Arcuate nucleus; Ghrelin; Growth hormone; Growth hormone releasing hormone; Neuropeptide Y

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GHRELIN; GROWTH HORMONE SECRETAGOGUE; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPLANT; FOOD INTAKE; GROWTH HORMONE RELEASE; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOMATOSTATIN RELEASE;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; GROWTH HORMONE-RELEASING HORMONE; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDE Y; PEPTIDE HORMONES; PITUITARY GLAND; PITUITARY HORMONE-RELEASING HORMONES; RATS; RATS, WISTAR; SOMATOSTATIN; VASOPRESSINS;

EID: 0036442864     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066629     Document Type: Article

References (45)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
2. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, van der Ploeg LH: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977.
3. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, van der Ploeg LH, Howard AD: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997;48:23-29.
4. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141:4255-4261.
5. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000;141:4325-4328.
6. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000;407:908-913.
7. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K: Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1980;106:663-667.
8. Smith RG, Palyha OC, Feighner SD, Tan CP, McKee KK, Hreniuk DL, Yang L, Morriello G, Nargund R, Patchett AA, Howard AD: Growth hormone-releasing substances: Types and their receptors. Horm Res 1999;51(suppl 3):1-8.
9. Nakagawa T, Ukai K, Ohyama T, Koida M, Okamura H: Effects of the synthesized growth hormone-releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrate-treated low growth rats. Life Sci 1996;59:705-712.
10. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF: Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 1995;80:942-947.
11. Willesen MG, Kristensen P, Romer J: Colocalization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999;70:306-316.
12. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD: Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 1998;139:4420-4423.
13. Dickson SL, Luckman SM: Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997;138:771-777.
14. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337-345.
15. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198.
16. Small CJ, Morgan DG, Meeran K, Heath MM, Gunn I, Edwards CM, Gardiner J, Taylor GM, Hurley JD, Rossi M, Goldstone AP, O'Shea D, Smith DM, Ghatei MA, Bloom SR: Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci USA 1997;94:11686-11691.
17. McDonald JK, Lumpkin MD, Samson WK, McCann SM: Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci USA 1985;82:561-564.
18. Rettori V, Milenkovic L, Aguila MC, McCann SM: Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 1990;126:2296-2301.
19. Gillies G, Lowry P: Corticotrophin-releasing factor may be modulated vasopressin. Nature 1979;278:463-464.
20. Stanley SA, Small CJ, Kim MS, Heath MM, Seal LJ, Russell SH, Ghatei MA, Bloom SR: Agouti related peptide (Agrp) stimulates the hypothalamo-pituitary-gonadal axis in vivo and in vitro in male rats. Endocrinology 1999;140:5459-5462.
21. Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB: The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 1999;11:521-528.
22. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR: The central melanocortin system affects the hypothalamopituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000;105:1005-1011.
23. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego, Academic Press, 1998.
24. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M: Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 2000;275:477-480.
25. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal L, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR: Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-2547.
26. Stanley SA, Small CJ, Murphy KG, Rayes E, Abbott CR, Seal LJ, Morgan DG, Sunter D, Dakin CL, Kim MS, Hunter R, Kuhar M, Ghatei MA, Bloom SR: Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 2001;893:186-194.
27. Satoh F, Beak SA, Small CJ, Falzon M, Ghatei MA, Bloom SR, Smith DM: Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: Lack of coupling to either stimulation or inhibition of adenylyl cyclase. Endocrinology 2000;141:1301-1309.
28. Bloom SR, Long RG: Radioimmuonassays of Gut Regulatory Peptides. Philadelphia, WB Saunders, 1982.
29. Hickey GJ, Drisko J, Faidley T, Chang C, Anderson LL, Nicolich S, McGuire L, Rickes E, Krupa D, Feeney W, Friscino B, Cunningham P, Frazier E, Chen H, Laroque P, Smith RG: Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 1996;148:371-380.
30. Bowers CY: Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci 1998;54:1316-1329.
31. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V: Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 1994;135:1073-1076.
32. Kuriyama H, Hotta M, Wakabayashi I, Shibasaki T: A 6-day intracerebroventricular infusion of the growth hormone-releasing peptide KP-102 stimulates food intake in both non-stressed and intermittently-stressed rats. Neurosci Lett 2000;282:109-112.
33. Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA: Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab 1998;83:1186-1189.
34. Robinson BM, Friberg RD, Bowers CY, Barkan AL: Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone. J Clin Endocrinol Metab 1992;75:1121-1124.
35. Bowers CY, Sartor AO, Reynolds GA, Badger TM: On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991;128:2027-2035.
36. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E: Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001;86:1169-1174.
37. Tolle V, Zizzari P, Tomasetto C, Rio MC, Epelbaum J, Bluet-Pajot MT: In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology 2001;73:54-61.
38. Aguila MC, McCann SM: The influence of hGRF, CRF, TRH and LHRH on SRIF release from median eminence fragments. Brain Res 1985;348:180-182.
39. Meacham LR, Culler FL, Abdul-Latif H, Sullivan KM, Bowers CY: Preservation of growth hormone secretion in response to growth hormone-releasing peptide-2 during prednisone therapy. Metabolism 1999;48:585-589.
40. Thomas GB, Fairhall KM, Robinson IC: Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 1997;138:1585-1591.
41. Arvat E, Di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F, Ghigo E: Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides 1997;18:885-891.
42. Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ: The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 1999;84:2489-2495.
43. Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E: Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology 1997;66:432-438.
44. Horvath TL, Tschop M, Smith RG, Cowley MA, Cone RD, Diano S: Ghrelin: A novel hypothalamic neuropeptide with unique anatomical distribution. Soc Neurosci Abstr 2001;27:Abstract No. 789.3.
45. Pacak K, Palkovits M: Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev 2001;22:502-548.